BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rigoli L, Caruso RA. Mitochondrial DNA alterations in the progression of gastric carcinomas: Unexplored issues and future research needs. World J Gastroenterol 2014; 20(43): 16159-16166 [PMID: 25473169 DOI: 10.3748/wjg.v20.i43.16159] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Cavalcante GC, Marinho ANR, Anaissi AK, Vinasco-Sandoval T, Ribeiro-Dos-Santos A, Vidal AF, de Araújo GS, Demachki S, Ribeiro-Dos-Santos Â. Whole mitochondrial genome sequencing highlights mitochondrial impact in gastric cancer. Sci Rep 2019;9:15716. [PMID: 31673122 DOI: 10.1038/s41598-019-51951-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Liu Y, Zhang Z, Wang J, Chen C, Tang X, Zhu J, Liu J. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review. Onco Targets Ther 2019;12:1195-204. [PMID: 30863087 DOI: 10.2147/OTT.S189687] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 11.3] [Reference Citation Analysis]
3 Ieni A, Barresi V, Rigoli L, Caruso RA, Tuccari G. HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach. Dis Markers 2015;2015:234851. [PMID: 26494937 DOI: 10.1155/2015/234851] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
4 Terzioğlu G, Türksoy Ö, Bayrak ÖF. Identification of An mtDNA Setpoint Associated with Highest Levels of CD44 Positivity and Chemoresistance in HGC-27 and MKN-45 Gastric Cancer Cell Lines. Cell J 2018;20:312-7. [PMID: 29845783 DOI: 10.22074/cellj.2018.5309] [Cited by in F6Publishing: 4] [Reference Citation Analysis]